Hagay Sobol

10.8k total citations
113 papers, 2.8k citations indexed

About

Hagay Sobol is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Hagay Sobol has authored 113 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Genetics, 33 papers in Oncology and 30 papers in Pathology and Forensic Medicine. Recurrent topics in Hagay Sobol's work include BRCA gene mutations in cancer (55 papers), Genetic factors in colorectal cancer (28 papers) and Cancer Genomics and Diagnostics (16 papers). Hagay Sobol is often cited by papers focused on BRCA gene mutations in cancer (55 papers), Genetic factors in colorectal cancer (28 papers) and Cancer Genomics and Diagnostics (16 papers). Hagay Sobol collaborates with scholars based in France, United States and Canada. Hagay Sobol's co-authors include François Eisinger, Daniel Birnbaum, Claire Julian‐Reynier, Catherine Noguès, Dominique Stoppa‐Lyonnet, F Kerangueven, Tetsuro Noguchi, Philippe Vennin, Michel Longy and Violaine Bourdon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Hagay Sobol

109 papers receiving 2.7k citations

Peers

Hagay Sobol
Wendy Kohlmann United States
Henry T. Lynch United States
Wendy McKinnon United States
Lucy Side United Kingdom
Rolf H. Sijmons Netherlands
Hagay Sobol
Citations per year, relative to Hagay Sobol Hagay Sobol (= 1×) peers Ketil Heimdal

Countries citing papers authored by Hagay Sobol

Since Specialization
Citations

This map shows the geographic impact of Hagay Sobol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hagay Sobol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hagay Sobol more than expected).

Fields of papers citing papers by Hagay Sobol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hagay Sobol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hagay Sobol. The network helps show where Hagay Sobol may publish in the future.

Co-authorship network of co-authors of Hagay Sobol

This figure shows the co-authorship network connecting the top 25 collaborators of Hagay Sobol. A scholar is included among the top collaborators of Hagay Sobol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hagay Sobol. Hagay Sobol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamadou, Walid Sabri, Violaine Bourdon, Yosra Ben Youssef, et al.. (2017). GATA2 gene analysis in several forms of hematological malignancies including familial aggregations. Annals of Hematology. 96(10). 1635–1639. 6 indexed citations
2.
Hamadou, Walid Sabri, Violaine Bourdon, Yosra Ben Youssef, et al.. (2016). Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases. Familial Cancer. 16(1). 153–157. 6 indexed citations
3.
Noguchi, Tetsuro, Violaine Bourdon, & Hagay Sobol. (2014). About Sequence Quality: Impact on Clinical Applications. Genetic Testing and Molecular Biomarkers. 18(5). 299–305. 1 indexed citations
4.
Gilabert, Marine, Christophe Ginestier, François Bertucci, et al.. (2014). Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib. PLoS ONE. 9(8). e104302–e104302. 55 indexed citations
5.
Hassanein, Mohamed, Laëtitia Huiart, Violaine Bourdon, et al.. (2013). Prediction of BRCA1 Germ-Line Mutation Status in Patients with Breast Cancer Using Histoprognosis Grade, MS110, Lys27H3, Vimentin, and KI67. Pathobiology. 80(5). 219–227. 10 indexed citations
6.
Bourdon, Violaine, Laëtitia Huiart, François Eisinger, et al.. (2009). Molecular study of CEPBA in familial hematological malignancies. Familial Cancer. 8(4). 581–584. 4 indexed citations
7.
Huiart, Laëtitia, et al.. (2008). Acceptability of cancer chemoprevention trials: impact of the design. International Journal of Medical Sciences. 5(5). 244–247. 7 indexed citations
8.
Lassailly, François, Julien Mozziconacci, Tetsuro Noguchi, et al.. (2007). Comparison of a Selection of Rapid Automated DNA and RNA Extraction Technologies for Detection of Somatic or Constitutional Gene Abnormalities in Cancer Diagnosis. 5(1). 2–15. 3 indexed citations
9.
Eisinger, François, Brigitte Bressac–de Paillerets, Damienne Castaigne, et al.. (2006). Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l'ovaire (mise à jour 2004). Pathologie Biologie. 54(4). 230–250. 76 indexed citations
10.
Eisinger, François, Brigitte Bressac–de Paillerets, Damienne Castaigne, et al.. (2004). Identification and management of hereditary breast\ovarian cancers (2004 update). Bulletin du Cancer. 91(3). 219–237. 1 indexed citations
11.
Eisinger, François, Brigitte Bressac–de Paillerets, J. Lansac, et al.. (2004). Réponse du Groupe technique national sur le dépistage du cancer du sein. Bulletin du Cancer. 91(7). 656–656. 1 indexed citations
12.
Gonçalvès, Anthony, Patrice Viens, Hagay Sobol, D Maraninchi, & François Bertucci. (2004). Altérations moléculaires des cancers du sein : applications cliniques et nouveaux outils d'analyse. La Revue de Médecine Interne. 26(6). 470–478. 4 indexed citations
13.
Sobol, Hagay, Norbert Vey, R Sauvan, et al.. (2002). Re: Familial multiple myeloma: A family study and review of the literature (multiple letters). JNCI Journal of the National Cancer Institute. 94(6). 461–463. 8 indexed citations
14.
Moatti, Jean‐Paul, Claire Julian‐Reynier, François Eisinger, et al.. (2002). Testing for BRCA1 mutations: a cost-effectiveness analysis. European Journal of Human Genetics. 10(10). 599–606. 48 indexed citations
15.
Julian‐Reynier, Claire, François Eisinger, F Chabal, et al.. (2000). Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factors. American Journal of Medical Genetics. 94(1). 13–18. 93 indexed citations
16.
Sobol, Hagay, Yves‐Jean Bignon, Catherine Bonaïti, et al.. (1999). Four Years Analysis of Cancer Genetic Clinics Activity in France from 1994 to 1997: A Survey on 801 Patients. Disease Markers. 15(1-3). 15–29. 12 indexed citations
17.
Julian‐Reynier, Claire, François Eisinger, Jean‐Paul Moatti, & Hagay Sobol. (1999). French Physicians’ Knowledge about Hereditary Breast/Ovarian Cancer: The Need for Continuing Vocational Training in Genetics. Public Health Genomics. 2(4). 165–172. 8 indexed citations
18.
Essioux, Laurent, Olga M. Sinilnikova, François Eisinger, et al.. (1998). Marker segregation information in breast/ovarian cancer genetic counseling: Is it still useful?. American Journal of Medical Genetics. 79(3). 175–183. 4 indexed citations
19.
Julian‐Reynier, Claire, François Eisinger, F Chabal, et al.. (1996). Cancer genetics clinics: Target population and consultees' expectations. European Journal of Cancer. 32(3). 398–403. 32 indexed citations
20.
Schuffenecker, Isabelle, Steven A. Narod, R. Alan B. Ezekowitz, et al.. (1991). The gene for mannose-binding protein maps to chromosome 10 and is a marker for multiple endocrine neoplasia type 2. Cytogenetic and Genome Research. 56(2). 99–102. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026